» Articles » PMID: 37793761

Single-agent Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma

Overview
Journal Lancet Haematol
Specialties Hematology
Oncology
Date 2023 Oct 4
PMID 37793761
Authors
Affiliations
Soon will be listed here.
Citing Articles

Understanding the chemistry & pharmacology of antibody-drug conjugates in triple-negative breast cancer with special reference to exatecan derivatives.

Sawant S, Naik G, Sahu A, Jagtap V Med Oncol. 2024; 41(12):301.

PMID: 39460856 DOI: 10.1007/s12032-024-02542-y.